معرفی
Dr Ify Mordi is an Honorary Research Fellow at the University of Glasgow's School of Cardiovascular & Metabolic Health. Her research focuses on cardiovascular health, particularly heart failure mechanisms, myocardial infarction outcomes, and advanced cardiac imaging techniques such as MRI and CT angiography. She has contributed to studies on exercise rehabilitation for heart failure patients, biomarker-driven prognosis in chronic heart failure, and genomic consortia (e.g., HERMES) for heart failure analysis.
Her work spans clinical trials (e.g., serelaxin's vascular effects), pathophysiological insights (e.g., smoking impact on myocardial infarction outcomes), and imaging innovations (e.g., T2 mapping for infarct zone evaluation). Collaborations include the SCOT-HEART investigators and BIOSTAT-CHF analyses. Key areas include therapeutic optimization in heart failure, microvascular dysfunction in acute coronary syndromes, and prognostic biomarkers.
Publications highlight her expertise in cardiac imaging applications, pharmacotherapy evaluation, and translational research bridging genomics and clinical cardiology. Her research aims to improve patient stratification, treatment efficacy, and long-term outcomes in cardiovascular diseases through multidisciplinary approaches.